A Study to Evaluate Lenti-HPV-07 Immunotherapy Against HPV+ Cervical or Oropharyngeal Cancer

Clinical trial NCT06319963 · RECRUITING

Trial details

NCT number: NCT06319963
Sponsor: Theravectys S.A.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

HPV-Related Cervical Carcinoma HPV Positive Oropharyngeal Squamous Cell Carcinoma

Start date: 2024-08-08
Primary completion: 2026-06-01
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.